International Conference on Prevention & Infection Control (ICPIC 2027)
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Conference on Prevention & Infection Control (ICPIC 2027) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds
About this event
ICPIC 2027 | 9th International Conference on Prevention & Infection Control
The 9th International Conference on Prevention & Infection Control (ICPIC 2027) is taking place in Geneva, Switzerland from 14 to 16 September 2027. ICPIC positions itself as a leading global forum for the infection prevention and control (IPC) community, bringing together healthcare professionals, researchers, and industry partners focused on strengthening patient and healthcare worker safety worldwide.
Purpose and mission
ICPIC 2027 is dedicated to advancing practical and evidence-based strategies to prevent healthcare-associated infections, address antimicrobial resistance, and enhance the safety of patients and healthcare workers. The conference theme and programming are built around real-world impact—supporting professionals and organizations that work on prevention, surveillance, antimicrobial stewardship, and infection control implementation.
Conference leadership
The conference is chaired by Prof. Didier Pittet (Chair) and Prof. Stephan Harbarth (Co-Chair). Their leadership reflects ICPIC’s focus on global relevance, scientific rigor, and actionable guidance for infection prevention and control programs.
What to expect at ICPIC 2027
- Scientific content: ICPIC 2027 includes submission opportunities for oral free papers and posters, with accepted abstracts intended for publication in the ARIC journal (the official ICPIC journal).
- Conference scale: The program highlights include more than 100 oral free papers and 500 selected posters.
- Post-event access: All sessions will be recorded and made available after the meeting on the ICPIC learning portal, supporting a richer participant experience beyond the live dates.
- Industry participation: Companies are invited to showcase their services and product at the exhibition or through a sponsored integrated symposium.
- Innovation elements: The event includes the ICPIC Innovation Academy and the ICPIC Clip Award, designed to spotlight innovation and promote engagement across the IPC community.
Important dates (as published)
- Abstract submission notification: from 1 December 2026 to 26 March 2027.
- Early bird registration deadline: 26 March 2027.
Where ICPIC 2027 is held
ICPIC 2027 takes place in Geneva, Switzerland from 14 to 16 September 2027. (Further venue location details can be confirmed on the event’s venue and location sections.)
Why ICPIC 2027 matters for prevention & infection control
ICPIC is built for an audience that needs both scientific updates and practical implementation support. For professionals working across infection prevention and control programs, antimicrobial resistance initiatives, healthcare epidemiology, and patient safety, ICPIC 2027 offers a structured platform to share research, evaluate approaches, and connect with global stakeholders. With a strong blend of oral sessions, posters, recordings, and industry engagement, the conference supports learning before, during, and after the meeting.
Data sheet
International Conference on Prevention & Infection Control (ICPIC 2027) – Event Attendee & Buyer Profile Analysis
Event Date: 14–16 September 2027
Location: Geneva, Switzerland
Event Status: Upcoming
Research Date: 1 July 2026
Location: Geneva, Switzerland
Event Status: Upcoming
Research Date: 1 July 2026
Event Overview
| Event Name | International Conference on Prevention & Infection Control (ICPIC 2027) |
| Event Date | 14–16 September 2027 |
| Event Status | Upcoming |
| Venue | Centre International de Conférence de Genève (CICG) |
| City | Geneva |
| State / Region | Geneva Canton |
| Country | Switzerland |
| Organizer | ICPIC / MCI Agency (event management) |
| Official Event Website | conference.icpic.com |
| Event Type | International scientific conference with education, research presentation, sponsorship, and exhibition opportunities |
| Primary Category | Medical & Pharma |
| Secondary Applicable Categories | Science & Research; Business Services; Security & Defense |
| Audience Reach | Global |
| Estimated Attendance / Expected Footfall | Attendance figure not publicly confirmed by the organizer. Historic program content indicates more than 100 oral free papers and 500 selected posters will be presented. |
| Attendance Data Reliability | Medium: official event website confirms format, scientific scale, and participation opportunities, but does not publish a full attendee count. |
| Main Purpose of Event | To bring together the global infection prevention and control community to share research, improve patient and worker safety, address antimicrobial resistance, and showcase products, services, and solutions relevant to healthcare infection control. |
About the Event
ICPIC 2027 is the 9th edition of the International Conference on Prevention & Infection Control, positioned as a leading global forum for the infection prevention and control community. The official program emphasizes healthcare-associated infection prevention, antimicrobial resistance, patient safety, and safety for healthcare workers, making the event highly relevant to hospital systems, public health institutions, clinical researchers, and suppliers of infection-control technologies and consumables.
The event combines scientific sessions, oral free papers, selected posters, educational content, sponsored symposia, and exhibition participation. For B2B lead generation, ICPIC is especially relevant to organizations selling infection prevention products, sterilization and cleaning solutions, diagnostics, antimicrobial stewardship tools, hospital supplies, and digital platforms supporting clinical workflows and quality improvement.
1. Who Attends: Buyers / Attendees
| Buyer / Attendee Segment | Typical Organizations | Buying Role or Influence | Relevance to Exhibitors / Suppliers |
|---|---|---|---|
| Infection prevention & control leaders | Hospitals, academic medical centers, health systems | Clinical decision-making, product evaluation, protocol adoption | High-value audience for IPC products, training, and surveillance tools |
| Procurement and sourcing teams | Hospitals, integrated delivery networks, group purchasing organizations | Vendor selection, tendering, contract negotiation | Important for consumables, devices, and service contracts |
| Hospital administrators / operations leaders | Hospitals, clinics, surgical centers | Budget approval, operations improvement, compliance support | Relevant for workflow, compliance, and environmental hygiene solutions |
| Clinical microbiology and laboratory leaders | Hospitals, reference labs, research institutions | Testing protocols, diagnostics assessment, lab modernization | Strong fit for diagnostics, surveillance, and data platforms |
| Public health and government buyers | Health ministries, public health institutes, national infection control programs | Policy, program funding, guideline adoption, procurement | Relevant for population-level prevention, surveillance, and readiness solutions |
| Nursing leadership | Hospitals, long-term care, outpatient care | Operational enforcement, staff training, adoption influence | Important for hand hygiene, PPE, and training products |
| Research and academic buyers | Universities, teaching hospitals, research centers | Evidence generation, pilot selection, grant-led adoption | Relevant for pilot programs, data tools, and research partnerships |
| Industry sponsors and solution providers | Medical device, pharma, diagnostics, hygiene, software firms | Commercial partnership, exhibition, lead generation | Core sponsor/exhibitor audience; also useful for partner mapping |
| Association leaders and KOLs | Professional societies, infection control associations, accreditation bodies | Influence, education, guideline dissemination | Useful for thought leadership and partnership opportunities |
2. Event Location and Attendee Geographic Origin
| Geographic Area | Likely Attendee Origin | Buyer Concentration | Notes |
|---|---|---|---|
| Host city: Geneva | Local hospitals, universities, international health organizations | High | Geneva is a major healthcare and international policy hub |
| Host region: Switzerland / nearby French-speaking region | Swiss hospitals, clinics, public health agencies, regional suppliers | High | Likely strong attendance from Swiss and neighboring francophone stakeholders |
| Nearby European business hubs | France, Germany, Italy, Benelux, UK, Nordics | Medium to High | Accessible travel corridor for clinical and supplier audiences |
| National reach | Healthcare, research, public sector, and supplier organizations from across Switzerland and Europe | High | Conference topic has broad clinical relevance across healthcare systems |
| International reach | Global infection prevention, public health, diagnostics, and hospital supply stakeholders | Very High | Official site describes ICPIC as a leading global forum |
3. Audience Reach
| Reach Level | Assessment | Explanation |
|---|---|---|
| Global | Primary classification | The official website explicitly positions ICPIC as a leading global forum for the infection prevention and control community. |
4. Sample Buyer Companies and Websites
| Buyer Company / Organization | Buyer Type | Why It Is Relevant | Website | Best Job Titles to Target | Evidence Level |
|---|---|---|---|---|---|
| Geneva University Hospitals (HUG) | Hospital system / public healthcare buyer | Institutional sponsor and highly relevant hospital buyer for IPC solutions | hug.ch | Chief Medical Officer, IPC Director, Procurement Director, Nursing Director | Confirmed Government / Procurement Organization |
| World Health Organization (WHO) | Global public health buyer / stakeholder | Geneva-based global health body relevant to infection prevention policy and programs | who.int | Program Manager, Public Health Lead, Technical Officer, Procurement Specialist | Strong Market Fit, Attendance Not Confirmed |
| Médecins Sans Frontières (MSF) | Humanitarian healthcare buyer | Uses infection prevention, sterilization, and field healthcare solutions | msf.org | Medical Procurement Lead, Supply Chain Manager, Field Operations Director | Strong Market Fit, Attendance Not Confirmed |
| International Committee of the Red Cross (ICRC) | Humanitarian health and procurement organization | Geneva-based organization with healthcare and field logistics purchasing needs | icrc.org | Procurement Officer, Logistics Manager, Health Program Lead | Strong Market Fit, Attendance Not Confirmed |
| Erasmus MC | Academic medical center | Research-driven hospital likely to value IPC evidence, diagnostics, and training | erasmusmc.nl | Infection Control Lead, Lab Director, Procurement Manager | Strong Market Fit, Attendance Not Confirmed |
| Charité – Universitätsmedizin Berlin | Hospital and research system | Large academic health system with infection control and procurement needs | charite.de | IPC Specialist, Procurement Lead, Clinical Operations Director | Strong Market Fit, Attendance Not Confirmed |
| Mayo Clinic | Hospital / health system buyer | Large-scale clinical buyer with high standards for infection prevention and quality | mayoclinic.org | Supply Chain Director, IPC Director, Quality Director | Strong Market Fit, Attendance Not Confirmed |
| Johns Hopkins Medicine | Academic medical center | Influential health system with research and clinical quality priorities | hopkinsmedicine.org | Procurement Manager, Infection Prevention Director, Lab Operations Lead | Strong Market Fit, Attendance Not Confirmed |
| NHS England | Public health system / government buyer | Large national healthcare buyer with infection prevention and procurement relevance | england.nhs.uk | Procurement Lead, IPC Lead, Clinical Policy Manager | Strong Market Fit, Attendance Not Confirmed |
| Public Health Agency of Canada | Government health buyer | Relevant for surveillance, prevention, and public health program solutions | canada.ca | Program Director, Procurement Officer, Public Health Analyst | Strong Market Fit, Attendance Not Confirmed |
| Robert Koch Institute | Public health research institute | Infection control research, surveillance, and policy stakeholder | rki.de | Research Director, Epidemiologist, Program Manager | Strong Market Fit, Attendance Not Confirmed |
| Cleveland Clinic | Hospital system | Large hospital buyer for IPC, sterilization, and care quality solutions | clevelandclinic.org | Supply Chain Director, Clinical Quality Lead, IPC Manager | Strong Market Fit, Attendance Not Confirmed |
| Becton, Dickinson and Company (BD) | Medical technology supplier and commercial partner | Potential sponsor/exhibitor relevant to hospitals and infection control workflows | bd.com | Business Development Director, Product Manager, Market Access Lead | Strong Market Fit, Attendance Not Confirmed |
| 3M Health Care | Healthcare products manufacturer | Relevant to wound care, sterilization, and infection prevention categories | 3m.com | Regional Sales Director, Product Manager, Clinical Education Manager | Strong Market Fit, Attendance Not Confirmed |
5. Job Profiles, Industries and Event Type
| Priority | Job Title / Function | Department | Seniority Level | Why This Role Matters |
|---|---|---|---|---|
| 1 | Chief Medical Officer | Executive / Clinical | C-Level | Influences quality, safety, and hospital-wide adoption |
| 2 | Director of Infection Prevention and Control | Clinical Quality / Infection Control | Director | Primary clinical buyer and evaluator for IPC solutions |
| 3 | Procurement Director | Procurement / Supply Chain | Director | Controls supplier onboarding and purchasing decisions |
| 4 | Strategic Sourcing Manager | Procurement | Manager | Evaluates vendors, pricing, and contracts |
| 5 | Nursing Director | Nursing | Director | Drives frontline compliance and product adoption |
| 6 | Hospital Operations Director | Operations | Director | Responsible for workflow efficiency and implementation |
| 7 | Microbiology Laboratory Director | Laboratory / Diagnostics | Director | Influences diagnostics, surveillance, and testing technology adoption |
| 8 | Quality Improvement Manager | Quality / Compliance | Manager | Focuses on patient safety metrics and process improvement |
| 9 | Public Health Program Manager | Government / Public Health | Manager | Relevant for policy-led prevention and surveillance programs |
| 10 | Business Development Director | Commercial | Director | Critical for sponsorships, partnerships, and market entry |
| Priority | Apollo Industry | Why It Fits the Event | Best Buyer Use Case |
|---|---|---|---|
| 1 | Hospital & Health Care | Core end-user audience for infection prevention solutions | Hospital buyers, infection control leaders, nursing leadership |
| 2 | Medical Devices | Suppliers of clinical products and infection-prevention devices | Product managers, commercial teams, OEM partnerships |
| 3 | Pharmaceuticals | Relevant to AMR, stewardship, and clinical prevention | Medical affairs, market access, public health partnerships |
| 4 | Biotechnology | Diagnostics, infection prevention innovation, research | R&D, translational research, clinical collaborations |
| 5 | Biotechnology | Academic and clinical research presence | Researchers, lab directors, innovation teams |
| 6 | Government Administration | Public health and hospital system buyers | Program managers, procurement officers, policy leads |
| 7 | Research | Scientific conference with abstract and poster program | Researchers, academic centers, evidence-generation partners |
| 8 | Health, Wellness & Fitness | Broader healthcare services ecosystem | Healthcare service operators and quality leaders |
| 9 | Logistics & Supply Chain | Procurement and hospital supply distribution relevance | Supply chain managers, distributors, fulfillment teams |
| 10 | Information Technology & Services | Digital surveillance, reporting, workflow, analytics | Health IT, data, interoperability, infection surveillance platforms |
| 11 | Medical Practice | Clinician-led participation and implementation | Physicians, practice managers, clinical directors |
| 12 | Environmental Services | Cleaning, disinfection, and hospital hygiene solutions | Facility leaders, infection prevention, housekeeping management |
6. Estimated Attendance
| Metric | Figure | Status | Source / Basis | Notes |
|---|---|---|---|---|
| Estimated total footfall | Not publicly confirmed | Confirmed unavailable | Official website does not publish attendee totals | Use only as a planning assumption, not a verified figure |
| Oral free papers | More than 100 | Confirmed | Official event website | Indicates strong scientific program scale |
| Selected posters | 500 | Confirmed | Official event website | Strong indicator of broad researcher participation |
| Exhibitor count | Not publicly confirmed | Unavailable | Official website mentions exhibition opportunities, but no count provided | Lead generation teams should verify via sponsorship prospectus |
| Speaker count | Not publicly confirmed | Unavailable | Agenda details not fully published in the source text provided | Potentially strong once programme is released |
| Sponsor count | Not publicly confirmed | Unavailable | Official page references institutional sponsors and sponsorship opportunities only | Confirm through sponsorship brochure if available |
7. Key Focus Areas and Buyer Engagement
| Focus Area | Typical Buyer Need | Buyer Engagement Opportunity | Relevant Supplier Offering |
|---|---|---|---|
| Infection prevention | Reduce HAIs and improve safety compliance | Clinical evidence discussions and product demos | Disinfection, hand hygiene, PPE, training tools |
| Antimicrobial resistance | Stewardship, surveillance, policy support | Thought leadership and evidence-based solutions | Diagnostics, analytics, stewardship software |
| Diagnostics and microbiology | Faster, more accurate lab-supported decision-making | Lab leader engagement and pilot discussions | Testing platforms, specimen handling, data systems |
| Patient and worker safety | Reduce exposure risk and improve compliance | Operational improvement conversations | Safety equipment, monitoring, education platforms |
| Research and abstracts | Publication, collaboration, and clinical validation | Partnering with academic and clinical innovators | Clinical trial services, research analytics, software |
| Education and training | Improve staff adoption and protocol adherence | Workshops, demos, CME-adjacent engagement | LMS, compliance training, e-learning content |
| Sponsored symposia and exhibition | Commercial visibility and pipeline generation | High-intent buyer and influencer conversations | Medtech, pharma, diagnostics, service offerings |
Lead Quality Assessment
| Factor | Assessment | Explanation |
|---|---|---|
| Buyer relevance | Very High | Direct relevance to hospital, public health, and clinical procurement stakeholders. |
| Decision-maker availability | High | Expected presence of directors, managers, researchers, and clinical leaders. |
| Data collection potential | High | Scientific conference format and sponsor/exhibition pathways support targeted prospecting. |
| Apollo targeting potential | Very High | Strong fit for healthcare, diagnostics, research, public health, and procurement filters. |
| Geographic targeting potential | High | Geneva creates strong European and international targeting opportunities. |
| Best outreach approach | High-touch, clinically credible, evidence-based | Best results come from role-based messaging, proof points, and product relevance to patient safety. |
| Overall lead quality | Very High | Strong event for lead generation, attendee profiling, and healthcare buyer engagement. |
| Best use case | B2B attendee list building, sponsorship targeting, and clinical account mapping | Ideal for companies selling IPC, diagnostics, hospital supplies, software, and services. |
| Limitations / risks | Moderate | Current-year attendee and exhibitor lists are not publicly confirmed in the provided source text. |
Apollo.io Targeting Recommendation
| Filter Type | Recommended Filters | Purpose |
|---|---|---|
| Apollo industries | Hospital & Health Care; Medical Devices; Pharmaceuticals; Biotechnology; Government Administration; Research; Information Technology & Services; Environmental Services; Logistics & Supply Chain | Focus on the most relevant buyer and influencer organizations |
| Departments | Procurement, Supply Chain, Clinical Operations, Quality, Infection Prevention, Nursing, Lab, Public Health, IT, Business Development | Reach actual decision-makers and implementers |
| Seniority | Manager, Director, VP, C-level, Head | Prioritize budget-holders and senior evaluators |
| Job titles | Chief Medical Officer, Infection Prevention Director, Procurement Director, Strategic Sourcing Manager, Nursing Director, Quality Director, Lab Director, Public Health Program Manager, Supply Chain Director, Business Development Director | Align outreach with high-intent roles |
| Geography | Switzerland, France, Germany, Italy, Benelux, UK, Nordics, broader EMEA, North America | Match likely attendee origin and international reach |
| Employee size | 201-500, 501-1000, 1001-5000, 5000+ | Prioritize hospitals, health systems, and large suppliers |
| Keywords | infection prevention, infection control, hospital hygiene, antimicrobial resistance, patient safety, sterilization, disinfection, healthcare-associated infection, HAI, surveillance, public health | Capture highly relevant titles and organizations |
| Company type | Hospital systems, academic medical centers, public health agencies, research institutes, medical device manufacturers, diagnostics firms | Separate true buyers from commercial partners |
| Revenue / public filters | Use large-enterprise and public-institution prioritization where available | Helps focus on organizations with formal procurement processes |
Suggested Apollo Search Logic: (“infection prevention” OR “infection control” OR “patient safety” OR “hospital hygiene” OR “antimicrobial resistance” OR “sterilization” OR “disinfection” OR “healthcare-associated infection”) AND (procurement OR sourcing OR clinical operations OR quality OR nursing OR lab OR public health OR supply chain) AND seniority:(Manager OR Director OR VP OR C-Level).
Client Fit Review Required
Please share the client website or product/service details. I will review the client offering and identify the highest-fit buyer companies, Apollo industries, seniority levels, departments, and job titles from this event.
Sources & Verification Notes
| Source | Type | What It Verified | Reliability |
|---|---|---|---|
| ICPIC 2027 Official Website | Official organizer source | Event name, dates, Geneva location, global positioning, abstract timeline, exhibition/sponsorship mention, poster/oral paper scale | Very High |
| ICPIC Venue Page | Official event page | Venue reference for Centre International de Conférence de Genève (CICG) | Very High |
| ICPIC About Geneva Page | Official event page | Host city context and regional relevance | High |
| ICPIC Homepage Sponsorship / Programme References | Official event page | Sponsorship opportunities, exhibition mention, scientific programme scale | Very High |
🎯 Selling to this event's audience? Get a free tailored buyer list
Tell us your work email and our AI instantly builds a buyer list matched to International Conference on Prevention & Infection Control (ICPIC 2027) — the best‑fit companies to target, the exact decision‑maker job titles, and the industry filters that fit what you sell.
🔒 Get my buyer details Free · ~20 seconds